WALD — Waldencast Share News
0.000.00%
Last trade - 00:00- $220.61m
- $364.97m
- $272.07m
Brief: Waldencast Announces Conclusion Of SEC Investigation
UK’s Waldencast posts flat Q4 revenue on Milk Makeup weakness, withholds outlook
Brief: Waldencast Reports Fourth Quarter Results
Corrected: BRIEF-Waldencast plc. Q4 Adjusted EBITDA USD 6.6 Million
Brief: Obagi Medical And It’S A Secret Med SpA Announce Collaboration In The Aloha Program
NASDAQ RESUMED AT 04:40 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:42 PM
U.S. STOCKS ON THE MOVE-Merck, Genco, Tesla
Waldencast falls after quarterly sales miss
Brief: Waldencast Announces Q2 2025 Results And Provides Q3 2025 Trading Update
U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy
U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy
U.S. STOCKS ON THE MOVE-Waldencast, Danaher, Asset Entities
Waldencast rises after US FDA clears its facial filler
Brief: Waldencast To Undertake Strategic Alternatives Review
Brief: Waldencast Acquires Novaestiq Corp. And U.S. Rights To Leading Injectable Hyaluronic Acid Gel Line, Saypha, Under The Obagi Medical Brand
Waldencast PLC expected to post a loss of 4 cents a share - Earnings Preview
Waldencast PLC expected to post a loss of 5 cents a share - Earnings Preview
Waldencast PLC reports results for the quarter ended September 30 - Earnings Summary